ReviewFrontiers in oncology2021

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy.

Peipei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.